FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid
The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.
The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.
What's Your Reaction?
